会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明申请
    • NOVEL ANTIGEN BINDING MOLECULES FOR THERAPEUTIC, DIAGNOSTIC, PROPHYLACTIC, ENZYMATIC, INDUSTRIAL, AND AGRICULTURAL APPLICATIONS, AND METHODS FOR GENERATING AND SCREENING THEREOF
    • 用于治疗,诊断,预防,食用,工业和农业应用的新型抗原结合分子及其产生和筛选的方法
    • WO2002092780A2
    • 2002-11-21
    • PCT/US2002/015767
    • 2002-05-17
    • DIVERSA CORPORATIONSHORT, Jay, M.
    • SHORT, Jay, M.
    • C12N
    • C12N15/1093C12N15/102C12N15/1027C12N15/66
    • The invention is directed to methods for generating sets, or libraries, of nucleic acids encoding antigen-binding sites, such as antibodies, antibody domains or other fragments, including single and double stranded antibodies, major histocompatibility complex (MHC) molecules, T cell receptors (TCRs), and the like. This invention provides methods for generating variant antigen binding sites, e.g., antibodies and specific domains or fragments of antibodies (e.g., Fab or Fc domains), by altering template nucleic acids including by saturation mutagenesis, synthetic ligation reassembly, or a combination thereof. In one aspect, the invention provides methods for generating all human or humanized antibodies and evolving them to achieve optimized properties related to stability, duration, expression, production, enzymatic activity, affinity, avidity, localization, and other immunological properties. Polypeptides generated by these methods can be analyzed using a novel capillary array platform, which provides unprecedented ultra-high throughput screening.
    • 本发明涉及用于产生编码抗原结合位点的核酸(例如抗体,抗体结构域或其它片段,包括单链和双链抗体,主要组织相容性复合体(MHC)分子,T细胞受体 (TCR)等。 本发明提供了通过改变模板核酸,包括饱和诱变,合成连接重组或其组合来产生变体抗原结合位点,例如抗体和抗体的特异结构域或片段(例如,Fab或Fc结构域)的方法。 一方面,本发明提供了产生所有人源化或人源化抗体并进化出来以实现与稳定性,持续时间,表达,产生,酶活性,亲和力,亲合力,定位和其他免疫学性质相关的优化性质的方法。 通过这些方法产生的多肽可以使用新颖的毛细管阵列平台进行分析,提供前所未有的超高通量筛选。
    • 22. 发明申请
    • WHOLE CELL ENGINEERING BY MUTAGENIZING A SUBSTANTIAL PORTION OF A STARTING GENOME, COMBINING MUTATIONS, AND OPTIONALLY REPEATING
    • 通过将起始基因组的重要部分,组合突变和可选择重复的整体细胞工程整合
    • WO0229032A2
    • 2002-04-11
    • PCT/US0131004
    • 2001-10-01
    • DIVERSA CORPSHORT JAY MFU PENGCHENGLATTERICH MARTINWEI JINGLEVIN MICHAEL
    • SHORT JAY MFU PENGCHENGLATTERICH MARTINWEI JINGLEVIN MICHAEL
    • C12N15/10C12N15/82G01N33/534G01N33/68C12N15/00
    • C12N15/1089C12N15/102C12N15/1027C12N15/1058C12N15/8241G01N33/534G01N33/6848G01N2800/52
    • An invention comprising cellular transformation, directed evolution, and screening methods for creating novel transgenic organisms having desirable properties. In one embodiment, this invention provides a method of generating a transgenic organism, such as a microbe or a plant, having a plurality of traits that are differentially activatable. This invention also provides a method of retooling genes and gene pathways by the introduction of regulatory sequences, such as promoters, that are operable in an intended host, this conferring operability to a novel gene pathway when it is introduced into an intended host. For example a novel man-made gene pathway, generated based on microbially-derived progenitor templates, that is operable in a plant cell. This invention also provides a method of generating novel host organisms having increased expression of desirable traits, recombinant genes, and gene products. This invention provides novel methods for determining polypeptide profiles, and protein expression variations, which methods are applicable to all sample types disclosed herein. The present invention provides methods of simultaneously identifying and quantifying individual proteins in complex protein mixtures. Additionally this invention provides methods for cellular and metabolic engineering of new and modified phenotypes by using "on-line" or "real-time" metabolic flux analysis.
    • 一种包含细胞转化,定向进化和用于产生具有所需性质的新型转基因生物的筛选方法的发明。 在一个实施方案中,本发明提供了产生具有差异可激活的多种性状的转基因生物体如微生物或植物的方法。 本发明还提供了通过引入可在预期宿主中操作的调节序列(例如启动子)来重新组合基因和基因途径的方法,当将其导入预期的宿主时,这赋予了新基因途径的可操作性。 例如,基于微生物来源的祖细胞模板产生的新型人造基因途径,其可在植物细胞中操作。 本发明还提供了产生具有所需性状,重组基因和基因产物表达增加的新型宿主生物的方法。 本发明提供了用于确定多肽谱和蛋白质表达变化的新方法,该方法适用于本文公开的所有样品类型。 本发明提供同时鉴定和定量复合蛋白质混合物中的各种蛋白质的方法。 此外,本发明通过使用“在线”或“实时”代谢通量分析提供新的和修饰的表型的细胞和代谢工程的方法。
    • 23. 发明申请
    • SCREENING METHODS FOR ENZYMES AND ENZYME KITS
    • 酶和酶合成酶的筛选方法
    • WO1997004077A1
    • 1997-02-06
    • PCT/US1996011854
    • 1996-07-17
    • RECOMBINANT BIOCATALYSIS, INC.SHORT, Jay, M.MARRS, BarrySTEIN, Jeffrey, L.
    • RECOMBINANT BIOCATALYSIS, INC.
    • C12N09/00
    • C12N15/1086C12N15/1034C12N15/1079C12N15/1093C12N15/52C12Q1/00
    • Recombinant enzyme libraries and kits where a plurality of enzymes are each characterized by different physical and/or chemical characteristics and classified by common characteristics. The characteristics are determined by screening of recombinant enzymes expressed by a DNA library produced from various microorganisms. Also disclosed is a process for identifying clones of a recombinant library which express a protein with a desired activity by screening a library of expression clones randomly produced from DNA of at least one microorganism, said screening being effected on expression products of said clones to thereby identify clones which express a protein with a desired activity. Also disclosed is a process of screening clones having DNA from an uncultivated microorganism for a specified protein activity by screening for a specified protein activity in a library of clones prepared by (i) recovering DNA from a DNA population derived from at least one uncultivated microorganism; and (ii) transforming a host with recovered DNA to produce a library of clones which is screened for the specified protein activity.
    • 重组酶文库和试剂盒,其中多个酶各自以不同的物理和/或化学特征为特征,并通过共同特征分类。 通过筛选由各种微生物产生的DNA文库表达的重组酶来确定特征。 还公开了通过筛选由至少一种微生物的DNA随机产生的表达克隆文库来鉴定表达具有所需活性的蛋白质的重组文库的克隆的方法,所述筛选是对所述克隆的表达产物进行鉴定,从而鉴定 表达具有所需活性的蛋白质的克隆。 还公开了通过筛选通过(i)从源自至少一个未培养微生物的DNA群体中回收DNA的克隆文库中筛选特定蛋白质活性来筛选具有来自未培养的微生物的具有DNA的克隆的克隆的方法,以获得特定的蛋白质活性; 和(ii)用回收的DNA转化宿主以产生筛选特定蛋白质活性的克隆文库。